BendaRx Corp.
|
|||
| Mailing Address: | 1000 rue De La Gauchetière Ouest Suite 2400 Montréal, Québec H3B 4W5 |
Head Office Address: | 1000 rue De La Gauchetière Ouest Suite 2400 Montréal, Québec H3B 4W5 |
| Contact Name: | Martin Noël | Principal Regulator: | Non-Reporting Issuer |
| Business e-mail address: | mnoel@softkemopharma.com | Short Form Prospectus Issuer: | No |
| Telephone Number: | 514 212-2135 | Reporting Jurisdictions: | Non-Reporting Issuer |
| Fax Number: | Stock Exchange: | N/A | |
| Date of Formation: | Mar 14 2017 | Stock Symbol: | |
| Jurisdiction Where Formed: | Canada | Auditor: | Ernst & Young |
| Industry Classification: | other | General Partner: | |
| CUSIP Number: | Transfer Agent: | ||
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | Under $5,000,000 |
|
